Publicacions en col·laboració amb investigadors/es de Instituto de Investigación Biomédica de Lleida (26)

2024

  1. Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review

    Cancers, Vol. 16, Núm. 1

2023

  1. Molecular Pathology of Endometrial Tumors

    Molecular Surgical Pathology: Second Edition (Springer International Publishing), pp. 297-321

2022

  1. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma

    Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259

  2. Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition

    Scientific Reports, Vol. 12, Núm. 1

  3. M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors

    British Journal of Cancer

  4. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

2021

  1. Endometrial pten deficiency leads to smad2/3 nuclear translocation

    Cancers, Vol. 13, Núm. 19

2020

  1. Small-molecule inhibitors (Smis) as an effective therapeutic strategy for endometrial cancer

    Cancers, Vol. 12, Núm. 10, pp. 1-26

  2. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma

    Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265

2019

  1. Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85

2018

  1. High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition

    Phytochemistry Reviews, Vol. 17, Núm. 2, pp. 195-209

2017

  1. A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium

    Cell Death and Differentiation, Vol. 24, Núm. 8, pp. 1443-1458

  2. Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy, Vol. 13, Núm. 3, pp. 608-624

  3. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    Journal of Pathology, Vol. 242, Núm. 2, pp. 152-164

  4. Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026

2016

  1. Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies

    Blood, Vol. 127, Núm. 15, pp. 1907-1911

  2. Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias

    European Journal of Cancer, Vol. 63, pp. 74-87

  3. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget, Vol. 7, Núm. 32, pp. 52364-52374

  4. Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 4, pp. 526-535

2014

  1. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

    Carcinogenesis, Vol. 35, Núm. 12, pp. 2679-2686